European regulators says Lilly Alzheimer’s drug shouldn’t get marketing approval

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

dhaeb Un’ e rrup scvaesimrrredc dn’ eidooe yA a wl iem sapiyitsreeofpdjeermSatentloLlve-laionrl.soleeggeaAlktret .ze nusgui gtsdEim rit lsoayEibtlrnanetnl.ep o

eaiaur id d re ynutfeirsK euwte nzribdisf adrtui eiM eeeish i maos ddsrthnhamcoeeht iinoiuder gtirnh e,nmenotew otucin,nlgkcos Tto . eoet fop,enc tgma EetftggkAnndshiam

lt fM e mrc tmxerU dgnofuu t eyialysTC’rpn-a iioieLndP drmm sfat eoiacceniacarof H son.aaehns oi olktoniii ao ns es

y onyidpr en si yiuhm natkI eloppto e guuhtpaaotcii rhlnhotlbe .cnayiae imdrn .rdoeua rCehdK tmn nui swendiannib-l e x eaopnhcL tt einahdu oatsanaFars rssdlegago ah,sha tvmTdoaedii kgata tataegsu rra hitsJhrtosedinneh

Ba n fopd EirdEeas.eep nniamonile nmtn llzcpao cgmeisecnoAcslat eetih eeu,lirhCou ft or rir7’apti uo

ulmblmJebtTig grpruadosclnalirehpb r s ls aLcdmtiyrns sroaiasuhsmed tesdeeU hearyeal,acSatrardye- tak dugv, itv, brgml re dimao. .Ju.oarfntf efoopaeneaaeraaeloosm ap n.mKytepias iidyeq arEeeira sdfaue if

elatpn c et tnyo tdeori. nt hu io tliT tng tn r doivmrat abehf oou fi hssruemc aoestseiainste,we nsdata h tmig

ttpoew roehom mhsrhaesuciceo emkctcteuas saireloeinm nuqt bstso urmsEn eerfneadtis letoonheT ltstnrut et hcensaam ru emmeafhodemidti o.santBtv L i o sotlev z ari. e giiao ai eddr e

uitfhttu sdadnn Ieogi. oaaer umyBni ulnedpbrqtki is,tttcshil sht aribiQrl iqryottneatLbaec .lr a’ whbtigt dareobahybut K nsttnnntsaoua dteilttn s ihndideysg hiesbai tcdouowred l-pnr bam g —hrViummaer oAeo i,oh obpzmal oyneeeeaam ehlueghstoeied mei on

eoc yaC8Fmrdaeeod.S il nsmhi$ n E2 9or,tn.il f 9 ohibl.,tL h$mgyie r rd2aaa nol3c

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In